USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
World Blood Pathogen Reduction Markets
World Blood Pathogen Reduction Markets
RELEASE DATE
20-Feb-2003
20-Feb-2003
REGION
North America
North America
Research Code: A332-01-00-00-00
SKU: HC00859-NA-MR_04588
$2,450.00
Special Price $1,837.50 save 25 %
In stock
SKU
HC00859-NA-MR_04588
Description
This report focuses on those pathogen reduction technologies that address a broad range of blood pathogens. The role of potentially complementary or substitute products to these broader scope technologies, such as nucleic acid testing and artificial blood are discussed. This report begins with an analysis of the technologies that are expected to enter different markets, then discusses market dynamics and different target markets and sub-segments in which these technologies will compete. Finally, the report focuses on the strategy elements related to competition within the market.
Table of Contents
Executive Summary
- Executive Summary
Introduction
- Focus of the Report and Methodology
- Blood Pathogen and Immunological Transfusion Risks
- Introduction to Main Industry Participants
Technology Platform Overview
Marketed Technologies
- Introduction
- Adoption of Marketed Technologies and Pipeline Outlook
Cerus and Baxter: Helinx S-59 Psoralen Compound for Platelets and Plasma
- Solvent/Detergent
- Filtration
- Gamma Irradiation
- Methylene Blue
Cerus and Baxter: S-303 FRALE Compound for Red Blood Cells
- Technology Overview
- Efficacy Against Pathogens and White Blood Cells
- Toxicity and Damage to Blood Products
Vitex: Inactine PENN110 for Red Blood Cells
- Technology Overview
- Efficacy Against Pathogens and White Blood Cells
- Toxicity and Damage to Blood Products
Gambro PRT: Riboflavin for Platelets Plasma and Red Blood Cells
- Technology Overview
- Efficacy Against Pathogens and White Blood Cells
- Toxicity and Damage to Blood Products
Other Technology Platforms
- Technology Overview
- Efficacy Against Pathogens and White Blood Cells
- Toxicity and Damage to Blood Products
Substitutes and Complementary Products
- American Red Cross: Dimethylmethylene Blue for Platelets Plasma and Red Blood Cells
- Maxwell Technologies: Broad Spectrum Pulse Light
- Altachem: Bionex
Market Overview
Demand Analysis and Regulatory Issues
Drivers of Market Adoption
Restraints to Market Adoption
Segment Analysis and Revenue Forecasts
Competitive Analysis
Challenges and Strategies
Awards
Popular Topics
This report focuses on those pathogen reduction technologies that address a broad range of blood pathogens. The role of potentially complementary or substitute products to these broader scope technologies, such as nucleic acid testing and artificial blood are discussed. This report begins with an analysis of the technologies that are expected to enter different markets, then discusses market dynamics and different target markets and sub-segments in which these technologies will compete. Finally, the report focuses on the strategy elements related to competition within the market.
| No Index | No |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | A332-01-00-00-00 |
| Is Prebook | No |